PASG logo

Passage Bio (PASG) EBIT

Annual EBIT

-$103.00 M
+$32.40 M+23.93%

31 December 2023

PASG EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EBIT

-$15.91 M
+$1.03 M+6.10%

30 September 2024

PASG Quarterly EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBIT

-$69.34 M
+$7.38 M+9.61%

30 September 2024

PASG TTM EBIT Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PASG EBIT Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-+13.8%+32.7%
3 y3 years+42.0%+68.3%+61.0%
5 y5 years-180.7%-17.0%-89.0%

PASG EBIT High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+42.0%at high+68.3%at high+61.8%
5 y5 years-180.7%+42.0%-17.0%+68.3%-89.0%+61.8%
alltimeall time-920.3%+42.0%-279.9%+68.3%-1556.2%+61.8%

Passage Bio EBIT History

DateAnnualQuarterlyTTM
Sept 2024
-
-$15.91 M(-6.1%)
-$69.34 M(-9.6%)
June 2024
-
-$16.94 M(-6.1%)
-$76.72 M(-9.9%)
Mar 2024
-
-$18.05 M(-2.1%)
-$85.17 M(-17.3%)
Dec 2023
-$103.00 M(-23.9%)
-$18.45 M(-20.8%)
-$103.00 M(-8.7%)
Sept 2023
-
-$23.28 M(-8.3%)
-$112.80 M(-2.4%)
June 2023
-
-$25.39 M(-29.2%)
-$115.54 M(-11.1%)
Mar 2023
-
-$35.88 M(+27.0%)
-$129.97 M(-4.0%)
Dec 2022
-$135.39 M(-23.8%)
-$28.24 M(+8.5%)
-$135.39 M(-13.9%)
Sept 2022
-
-$26.03 M(-34.6%)
-$157.31 M(-9.0%)
June 2022
-
-$39.81 M(-3.6%)
-$172.88 M(-4.8%)
Mar 2022
-
-$41.31 M(-17.6%)
-$181.61 M(+2.2%)
Dec 2021
-$177.73 M
-$50.16 M(+20.6%)
-$177.73 M(+7.3%)
DateAnnualQuarterlyTTM
Sept 2021
-
-$41.60 M(-14.3%)
-$165.63 M(+8.5%)
June 2021
-
-$48.53 M(+29.7%)
-$152.65 M(+16.2%)
Mar 2021
-
-$37.43 M(-1.6%)
-$131.42 M(+17.4%)
Dec 2020
-$111.90 M(+205.0%)
-$38.06 M(+32.9%)
-$111.90 M(+28.0%)
Sept 2020
-
-$28.63 M(+4.9%)
-$87.44 M(+24.1%)
June 2020
-
-$27.30 M(+52.4%)
-$70.45 M(+39.7%)
Mar 2020
-
-$17.91 M(+31.8%)
-$50.41 M(+37.4%)
Dec 2019
-$36.69 M(+263.4%)
-$13.59 M(+16.7%)
-$36.69 M(+58.8%)
Sept 2019
-
-$11.64 M(+60.2%)
-$23.10 M(+101.7%)
June 2019
-
-$7.27 M(+73.6%)
-$11.45 M(+173.6%)
Mar 2019
-
-$4.19 M
-$4.19 M
Dec 2018
-$10.10 M
-
-

FAQ

  • What is Passage Bio annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Passage Bio?
  • What is Passage Bio quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Passage Bio?
  • What is Passage Bio quarterly EBIT year-on-year change?
  • What is Passage Bio TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Passage Bio?
  • What is Passage Bio TTM EBIT year-on-year change?

What is Passage Bio annual earnings before interest & taxes?

The current annual EBIT of PASG is -$103.00 M

What is the all time high annual EBIT for Passage Bio?

Passage Bio all-time high annual earnings before interest & taxes is -$10.10 M

What is Passage Bio quarterly earnings before interest & taxes?

The current quarterly EBIT of PASG is -$15.91 M

What is the all time high quarterly EBIT for Passage Bio?

Passage Bio all-time high quarterly earnings before interest & taxes is -$4.19 M

What is Passage Bio quarterly EBIT year-on-year change?

Over the past year, PASG quarterly earnings before interest & taxes has changed by +$2.54 M (+13.76%)

What is Passage Bio TTM earnings before interest & taxes?

The current TTM EBIT of PASG is -$69.34 M

What is the all time high TTM EBIT for Passage Bio?

Passage Bio all-time high TTM earnings before interest & taxes is -$4.19 M

What is Passage Bio TTM EBIT year-on-year change?

Over the past year, PASG TTM earnings before interest & taxes has changed by +$33.66 M (+32.68%)